Skip to content

Nicotine Virtual Reality Conditioned Place Preference

Effect of Nicotine on Acquisition and Extinction of a Conditioned Place Preference in a Virtual Reality Environment

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06259630
Acronym
NEVE
Enrollment
0
Registered
2024-02-14
Start date
2015-11-03
Completion date
2018-06-22
Last updated
2024-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Addiction, Nicotine Use Disorder

Keywords

Nicotine

Brief summary

In this between-subjects, placebo controlled, double-blind study, the investigators will examine the effects of low oral doses of nicotine on the learning and extinction of a conditioned place preference acquired in a virtual reality environment by healthy human subjects. Physiological and subjective responses to the drug will also be monitored.

Detailed description

External cues and contexts contribute to the development of smoking and the use of other drugs, and drugs themselves can alter the value of conditioned cues. Interestingly, nicotine increases the acquisition of new learning, and has been considered as a cognitive enhancer. Nicotine also prolongs responding when responding is no longer rewarded, during extinction. Although many studies have examined the effects of drugs on learning (acquisition) and unlearning (extinction) in laboratory animals, few have investigated drug effects on learning in humans. Recently, novel procedures have been developed to study conditioning in humans, pairing initially neutral places with food, money or drugs. The investigators will use one of these procedures, a virtual place conditioning procedure, to study how nicotine affects the acquisition and extinction of conditioned behaviors in humans.

Interventions

DRUGNicotine

Participant receives oral dose of nicotine

DRUGPlacebo oral capsule

Participant receives oral dose of placebo

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects must have at least a high school education and be in good physical and mental health.

Exclusion criteria

* Individuals with current medical conditions, and/or a history of serious medical problems (e.g., cardiac, kidney, liver, and neurological). Additional

Design outcomes

Primary

MeasureTime frame
Virtual Environment LikingParticipant rate on a visual analog scale how much they prefer one virtual environment over another

Secondary

MeasureTime frame
Time spent in virtual environmentParticipants actively choose which environment to spend time in. The length of those virtual visits is measured and compared during the study sessions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026